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Wnt Inhibitory Factor 1a b s t r a c t
Wnts have a structure resembling a hand with ‘‘thumb” and ‘‘index” fingers that grasp the cysteine
rich domains of Frizzled receptors at two distinct binding sites. In the present work we show that
the WIF domain of Wnt Inhibitory Factor 1 is also bound by Wnts at two sites. Using C-terminal
domains of Wnt5a and Wnt7a and arginine-scanning mutagenesis of the WIF domain we demon-
strate that, whereas the N-terminal, lipid-modified ‘‘thumb” of Wnts interacts with the alkyl-
binding site of the WIF domain, the C-terminal domain of Wnts (Wnt-CTD) binds to a surface on
the opposite side of the WIF domain.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Wnts are large, lipid-modified extracellular growth factors that
play critical roles in embryonic development and stem cell
proliferation of Metazoa [1,2]. Wnts exert their effects through
the activation of different intracellular signal transduction
pathways [3].
Three distinct but interconnected signaling pathways (the
canonical Wnt/b-catenin pathway, the non-canonical Wnt/planar
cell polarity pathway and the Wnt/calcium pathway) have been
shown to mediate signaling through Wnt-Frizzled interactions
[4,5]. Canonical Wnt signals are transmitted through Frizzled fam-
ily receptors which form a co-receptor complex with the LDLreceptor Related Proteins LRP5/6. In the case of the Wnt/calcium
pathway binding of Wnts to the co-receptor complex leads to an
increase in intracellular calcium and activation of calmodulin-
regulated signaling cascade, whereas in the Wnt/planar cell polar-
ity pathway c-jun N-terminal kinase is the effector molecule [6].
The extracellular Wnt-binding domains of Frizzled receptors,
usually called Fz domains, have been shown to bind multiple Wnts
with high affinity, the specificity of Wnt signaling depends on the
affinities between various Wnt-Frizzled pairs [7,8].
Domains related to the Fz domain of Frizzled receptors were
also identified in Ror type receptor tyrosine kinases [9–11], raising
the possibility that these receptor tyrosine kinases may also be
directly involved in Wnt signaling. This prediction was confirmed
by several studies: Ror receptor tyrosine kinases do mediate sig-
naling cascades in response to Wnt stimulation [12–14].
The Fz domain is not the only domain type that has high affinity
for Wnts: the WIF domain of Wnt Inhibitory Factor 1 (WIF-1)
exerts its action by sequestering Wnts [15]. The extracellular part
of receptor tyrosine kinases of the Ryk family was also shown to
contain a WIF domain raising the possibility that these receptor
tyrosine kinases may also be involved in Wnt-binding [16]. This
prediction was confirmed by subsequent studies: there is increas-
ing evidence that Ryks are also involved in Wnt-binding and Wnt
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and structure of the active Wnt-Ryk complex. Some data suggest
that Ryks might mediate Wnt signaling independently of Frizzled
but may also function as a Frizzled co-receptor [21–22].
Signaling in the Wnt/b-catenin pathway is initiated by the for-
mation of ternary complexes consisting of a Wnt, a Frizzled (Fzd)
receptor and a low-density lipoprotein receptor-related protein
(LRP5 or LRP6). Although the molecular details of the protein–pro-
tein interactions mediating the formation of these ternary com-
plexes are not fully understood, it is well established that fatty
acid modification of Wnts plays a key role in the formation of
the active Wnt-receptor complex [23–25]. The importance of fatty
acid modification of Wnts is underlined by the recent discovery
that the secreted enzyme Notum inhibits Wnt signaling through
removal of the lipid that is linked to Wnt proteins [26–27].
Janda et al. [28] have solved the crystal structure of a binary
Wnt-receptor complex: Wnt8 of Xenopus (XWnt8) bound to the
ligand-binding domain of the cognate receptor, Frizzled-8. Analy-
ses of the crystal structure of this complex revealed that XWnt8
contains two distinct structural domains connected by a long lin-
ker region. The larger N-terminal domain is a helical bundle with
two long b-hairpin loops, b-hairpin 2 bearing the lipid-modified
residue. The four helices supporting these two b-hairpins form a
core aC-aF antiparallel bundle showing significant similarity to
saposin-like proteins, whereas the smaller C-terminal domain has
a cytokine-like hairpin loop structure [28,29]. A striking feature
of the C-terminal domain is the exposed finger fold consisting of
a long, twisted antiparallel b-strand connected by a b-hairpin
structure that is stabilized by several disulfide bridges [28–30].
In the XWnt8-Frizzled-8 complex, the two domain Wnt struc-
ture resembles a hand, where the N-terminal and C-terminal
domains provide the ‘‘thumb” and ‘‘index” fingers that grasp the
Frizzled receptor at two distinct binding sites [28]. The lipid group
at the tip of the N-terminal thumb is inserted into a deep groove
in the Wnt-binding domain of the receptor, whereas the tip of the
C-terminal ‘index finger’ interacts with residues on the opposite
side of the receptor [28]. Although three dimensional structures
of ternary Wnt-receptor complexes have not yet been solved,
mutational analysis of mouse Wnt3a revealed that the linker
connecting the N- and C-terminal domains participates in LRP6
binding [31].
The activity of Wnts is modulated by a variety of extracellular
proteins that interfere with the formation of the Wnt-receptor
complexes [32–34]. Dickkopf proteins bind to LRP5/6 preventing
the association of these co-receptors with Wnts, whereas Wnt
Inhibitory Factor 1, Cerberus and secreted Frizzled-related proteins
bind directly to Wnts blocking their binding to Wnt receptors.
Wnt Inhibitory Factor 1 is an extracellular protein containing a
WIF domain and five EGF repeats, the WIF domain being primarily
responsible for the Wnt inhibitory activity of the protein [15]. In
our earlier work we have solved the three dimensional structure
of the WIF domain of human WIF-1 by NMR spectroscopy and
identified an alkyl-binding site that we suggested to serve as a
binding site for the essential lipid groups of Wnts [35]. In an
attempt to localize the Wnt-binding site of the WIF domain of
Wnt Inhibitory Factor 1 we have subjected the WIF domain of
Wnt Inhibitory Factor 1 to structure-guided arginine-scanning
mutagenesis [36]. These studies have confirmed that the
alkyl-binding site of the WIF domain is critical for its interaction
with Wnts: substitution of residues known to interact with the ali-
phatic moiety of the alkyl-ligand resulted in significantly
decreased affinity for Wnts [36]. Nevertheless, none of these
mutations resulted in complete elimination of the binding of the
WIF domain to Wnts, suggesting that – in analogy with the
Wnt-Frizzled interaction – Wnts may bind to the WIF domain at
additional sites.In the present work we have tested this hypothesis using
C-terminal domains of Wnt5a and Wnt7a and arginine-scanning
mutagenesis of the WIF domain. Our studies suggest that whereas
the N-terminal, lipid-modified domains of Wnts interact with the
alkyl-binding site of the WIF domain, the C-terminal domains bind
to a surface on the opposite side of the WIF domain.
2. Materials and methods
See Supplementary file.
3. Results
3.1. Characterization of the C-terminal domains of Wnt5A and Wnt7a
The C-terminal domains of Wnt5a and Wnt7a, secreted by
Pichia pastoris were found to be N-glycosylated (Supplementary
Fig. 1), in harmony with the fact that both proteins are predicted
by the NetNGlyc 1.0 Server (http://www.cbs.dtu.dk/services/
NetNGlyc/) to contain N-glycosylated Asn-Xaa-Ser/Thr sequons at
equivalent positions: at GRLCNKTSEGMDGCELMCC in Wnt5a-CTD
and at GRACNKTAPQASGCDLMCC in Wnt7a-CTD. Treatment of
the recombinant proteins with Endoglycosidase H resulted in a sig-
nificant decrease in their apparent Mr values of Wnt5a-CTD
(33 kDa? 18 kDa) and Wnt7a-CTD (30 kDa? 16 kDa).
Although the three dimensional structures of Wnt5A and
Wnt7a are unknown, their homology with XWnt8 of Xenopus per-
mitted the construction of homology models based on the crystal
structure of the latter protein (see Supplementary file). In the crys-
tal structure of XWnt8 and the homology models of Wnt5A and
Wnt7a (Fig. 1A–C), a characteristic feature of the C-terminal
cytokine-like ‘finger’ domains is the presence of two long, twisted
P strands connected by a large loop at the tip of the fingers
(Fig. 1D –F). In the homology models of Wnt5A-CTD and Wnt7a-
CTD (see Supplementary file), the dominant secondary structure
is b-strand (31%) with little a-helix (7% and 0%, respectively). In
harmony with this conclusion, analyses of the circular dichroism
(CD) spectra of recombinantWnt5A-CTD andWnt7a-CTD with var-
ious CD analysis programs have revealed that the proteins contain
b-strands but little a-helix (see Supplementary file). For example,
analyses of the CD spectra of Wnt5a-CTD and Wnt7a-CTD with
the K2D3 program have shown that Wnt5a-CTD and Wnt7a-CTD
contain 3.6% and 1.4% a-helix and 31.9% and 34.9% b-strand,
respectively.
3.2. Interaction of the C-terminal domains of Wnt5A and Wnt7a with
the WIF domain
Studies on the interaction of soluble Wnt5a-CTD and Wnt7a-
CTD with immobilized wild type WIF domain using surface plas-
mon resonance (SPR) spectroscopy revealed that they have moder-
ate affinity (Kd of 3.5  107 M and 1.2  108 M, respectively) for
the inhibitor (Fig. 2 and Table 1). It should be noted that the affini-
ties of these Wnt-CTDs (C-terminal domain of Wnt) for immobi-
lized WIF are significantly lower than the affinities of the
corresponding full length Wnt5a and Wnt7a (8  1010 M and
3  109 M, respectively) [36]. This observation confirms that,
although the C-terminal finger domains of Wnts do contribute to
the Wnt–WIF interaction, the N-terminal regions of Wnts are also
critical for the high affinity WIF–Wnt interaction. Interestingly,
althoughWIF has 4-fold higher affinity for Wnt5a than for Wnt7a
[36] it has 30-fold higher affinity for Wnt7a-CTD than for Wnt5a-
CTD (Table 1). The most plausible explanation for this apparent
contradiction is that WIF has significantly higher affinity for the
N-terminal domain of Wnt5a than for that of Wnt7a.
B. Wnt5a C. Wnt7aA. XWnt8
F. Wnt7a-CTDD. XWnt8-CTD E. Wnt5a-CTD
Fig. 1. Homology models of Wnt5a, Wnt7a, Wnt5a-CTD and Wnt7a-CTD based on the crystal structure of XWnt8. The figure shows the structure of XWnt8 (A) and the
homology models of humanWnt5a (B) and human Wnt7a (C). For the sake of clarity, the C-terminal domains of XWnt8 (D) corresponding to Wnt5a-CTD (E) and Wnt7a-CTD
(F) are shown in the lower part of the figure. Note that the C-terminal ‘fingers’ are characterized by the presence of two long, twisted b strands connected by a large loop at the
tip of the fingers. The arrows in (E) and (F) indicate the N-glycosylation sites of Wnt5a-CTD andWnt7a-CTD. The homology models were computed using the crystal structure
of XWnt8 as a template. The proteins are colored from the N-terminal to the C-terminal end continuously in a rainbow spectrum (in the order violet, blue, green, yellow,
orange, red) to reflect the order of structural elements in the overall sequence of residues.
A B
Fig. 2. Characterization of the interaction of immobilized WIF domain of Wnt Inhibitory Factor 1 with Wnt5a-CTD and Wnt7a-CTD by surface plasmon resonance assays.
Various concentrations of Wnt5a-CTD (A) and Wnt7a-CTD (B) were injected over CM5 sensorchips containing immobilized WIF domain (at 0 s on the abscissa). The binding
phase lasted 240 s, followed by a washing phase. Association and dissociation rate constants were calculated by analysis of the sensorgrams of the binding and washing
phases, respectively. For each experiment one set of representative data of three parallels are shown; in each case SPR response increased parallel with the increase of analyte
concentration.
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CTD revealed that they have higher affinity for the WIF domain
than the glycosylated forms (Table 1) suggesting that the carbohy-
drate moieties attached to the N-glycosylation sites bury some
sites that may interact with the WIF domain. Nevertheless, the fact
that the glycosylated forms of Wnt5a-CTD and Wnt7a-CTD have
significant affinity for the WIF domain indicates that critical parts
of the interaction site remain exposed. Since in the homology mod-
els of Wnt5a-CTD and Wnt7a-CTD the N-glycosylation sites are at
the ‘bottom’ of the protruding cytokine-like folds (Fig. 1E and F), itseems likely that residues of these finger-like structures may be
most critical for the interaction with the WIF domain.
3.3. Identification of residues involved in the interaction of the WIF
domain with the C- terminal domains of Wnt5a and Wnt7a
In our earlier work we have shown that substitution of residues
of the alkyl-binding site of theWIF domain decreases the affinity of
the WIF domain for Wnts, suggesting that the alkyl-binding site
contributes significantly to the WIF–Wnt interaction, possibly
Table 1
Kinetic parameters of the interaction of glycosylated and deglycosylated forms of Wnt5a-CTD andWnt7a-CTD with immobilized wild type WIF domain of Wnt Inhibitory Factor 1.
The rate constants of the association and dissociation reactions and the equilibrium dissociation constants of the interactions were determined from surface plasmon resonance
measurements with the BIAevaluation software 4.1.
Interacting proteins K (M) ka (1/Ms) kd (1/s)
WIF – Wnt5a-CTD 3.46 ± 0.25  107 1.93 ± 0.14  103 6.69 ± 0.09  104
WIF – Wnt7a-CTD 1.22 ± 0.23  108 2.88 ± 0.45  104 3.52 ± 0.43  104
WIF – Wnt5a-CTD* 4.53 ± 0.58  108 1.51 ± 0.15  104 6.85 ± 0.14  104
WIF – Wnt7a-CTD* 4.89 ± 0.99  109 7.92 ± 0.28  104 3.87 ± 0.52  104
* The asterisks indicate proteins that were deglycosylated by endoglycosidase H treatment.
Table 3
Effect of mutations of the WIF domain on its interaction with Wnt5a. The ability of
soluble wild type or mutant WIF domains to inhibit binding of Wnt5a to immobilized
wild type WIF domain was monitored by competitive SPR analyses and the IC50
concentrations causing half-maximal inhibition were calculated from the observed
association rates, kobs. The table lists the ratios of IC50 values of soluble mutant WIF
domains relative to that determined for soluble wild type WIF domain on the same
chip.
Mutation I50 ratio
Wild type 1.0
I49RJ 2.4 ± 0.09
F51RJ 3.3 ± 0.86
F66RJ 2.1 ± 0.38
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terminal parts of Wnts [36].
As a further test of the assumption that the surface around the
alkyl-binding site of the WIF domain interacts with the N-terminal
part of Wnts, in the present work we have studied the interaction
of Wnt5a-CTD and Wnt7a-CTD with some alkyl-binding site
mutants of the WIF domain. These studies have shown that the
Ile49Arg, Phe51Arg and Phe66Arg mutations that significantly
lowered the affinity of the WIF domain for full-length Wnts [36]
had practically no effect on the interaction of WIF with Wnt5a-
CTD and Wnt7a-CTD: in competition assays the mutants were as
efficient as the wild type protein in preventing binding of Wnt-
CTDs to immobilized wild typeWIF (Table 2). This observation sug-
gests that the WIF–Wnt interaction mediated by Wnt-CTDs does
not involve the alkyl-binding site of the WIF domain.
In order to localize the region of the WIF domain that interacts
with Wnt-CTDs we have selected additional residues for arginine-
scanning mutagenesis (the list of residues subjected to mutagene-
sis is shown in Supplementary Table 1). Although we have selected
a total of thirteen positions of the WIF domain for arginine-
scanning mutagenesis, the effect of the Asp116Arg and Leu106Arg
mutations on the WIF-Wnt interaction could not be studied since
P. pastoris failed to secrete these mutant proteins. Inspection of
the crystal structure (2YGN.pdb) of the WIF domain [37] revealed
that a hydrogen bond connects the carboxyl oxygen of the
Asp116 side chain to the backbone nitrogen of Ser108. A possible
explanation why the mutant protein failed to be expressed is that
substitution of Asp116 with an arginine disrupts this hydrogen
bond and this may cause misfolding and degradation of the WIF
domain. A similar explanation may hold for the Leu106Arg mutant.
Leu106 of the WIF domain is part of a b-strand (residues 99–109)
that interacts with two antiparallel b-strands formed by residues
146–158 and 123–127. It seems likely that substitution of
Leu106 by arginine impairs the interaction of the three b-strands
causing misfolding and degradation of the mutant protein.
Our solution competition assays with the remaining eleven
mutants have revealed that substitution of residues Leu123,
Ile155 and Ile172 by arginine resulted in a detectable decrease in
the affinity for Wnt5a, the most significant effect being observedTable 2
Effect of mutations in the alkyl-binding site of the WIF domain on its interaction with
Wnt5a-CTD and Wnt7a-CTD. The ability of soluble wild type or mutant WIF domains
to inhibit binding of Wnt5a-CTD or Wnt7a-CTD to immobilized wild type WIF domain
was monitored by competitive SPR analyses and the IC50 concentrations causing half-
maximal inhibition were calculated from the observed association rates, kobs. The
table lists the ratios of IC50 values of soluble mutant WIF domains relative to that
determined for soluble wild type WIF domain on the same chip.
Mutation Wnt5a-CTD Wnt7a-CTD
I50 ratio I50 ratio
Wild type 1.00 1.00
I49R 0.9 ± 0.16 1.0 ± 0.17
F51R 1.0 ± 0.18 1.1 ± 0.15
F66R 0.9 ± 0.21 1.0 ± 0.21in the case of the Ile155Arg mutant (Table 3). Inspection of the
structure of the WIF domain reveals that residue Ile155 is distant
from the alkyl-binding site of the WIF domain (Fig. 3), consistent
with the notion that the Ile155Arg mutation of WIF affects interac-
tions that do not involve the N-terminal domain of Wnt5a.
To test the assumption that the Ile155 residue of WIF is located
in the region that serves as a Wnt-CTD-binding site we have mon-
itored the influence of this mutation on the interaction of WIF with
Wnt5a-CTD and Wnt7a-CTD. In harmony with this assumption our
competition assays revealed that the Ile155Arg mutation impaired
the ability of the mutant protein to compete with immobilized
wild type WIF domain for both Wnt5a-CTD and Wnt7a- CTD
(Fig. 4).
As a further test of the influence of the Ile155Arg substitution
on the WIF–Wnt interaction we have assayed the binding of full-
length Wnt5a, Wnt7a, Wnt5a-CTD and Wnt7a-CTD to Ile155Arg
mutant WIF immobilized on sensor chips (Table 4). In the case of
full-length Wnt5a the Ile155Arg mutation of WIF caused an
increase in Kd (Kd = 8  1010 M? Kd = 1.55  109 M), but a more
drastic reduction in affinity for Wnt5a-CTD was observed.
Although Wnt5a-CTD has significant affinity for wild type WIF
domain (Fig. 2, Table 1), no interaction could be detected by SPR
using immobilized Ile155Arg mutant WIFdomain.
The Ile155Arg mutation of WIF also caused some increase in
the Kd for the interaction with full-length Wnt7aH85R 0.8 ± 0.16
L104R 0.7 ± 0.25
T118R 1.1 ± 0.15
L123R 1.6 ± 0.41
T126R 0.5 ± 0.19
E151R 1.0 ± 0.21
I155R 3.0 ± 0.45
Q169R 0.5 ± 0.13
I172R 1.7 ± 0.46
F174R 1.3 ± 0.25
T176R 0.6 ± 0.07
L123R-F66RJ 3.6 ± 0.91
I155R-I49RJ 12.5 ± 2.9
I155R-F66RJ 4.9 ± 1.24
I172R-F51RJ 5.1 ± 1.12
 Double daggers indicate residues located in the alkyl-binding site of the WIF-
domain [18].
A B
Phe51
Phe66
Ile49
Ile155
Fig. 3. The surface of the WIF domain involved in its interaction with Wnt5a-CTD and Wnt7a-CTD is distinct from its alkyl-binding site. (A) The surface containing the alkyl-
binding site of the WIF domain. Residues Phe51, Phe66 and Ile49 whose substitution with arginine resulted in weaker binding for Wnts [18] are highlighted in green. (B) The
surface containing the binding site for Wnt5a-CTD and Wnt7a-CTD. Residue Ile155, whose substitution with arginine resulted in weaker binding for Wnt5a-CTD and Wnt7a-
CTD is highlighted in yellow. Residue numbering refers to the numbering of the WIF-1 protein in Uniprot entry Q9Y5W5. The WIF domain was modeled on PDB 2YGN, the
images were generated by YASARA version 7.10.31. (B) was generated by rotating figure (A) by 225 around the y-axis.
A B C
FED
Fig. 4. Effect of wild type and Ile155Arg mutant WIF domains on the binding of Wnt5a-CTD or Wnt7a-CTD to immobilized wild type WIF domain, monitored by surface
plasmon resonance. Upper row: sensorgrams of the interactions of immobilized WIF domain with Wnt5a-CTD (3 lM) (A) preincubated with 0 lM, 5 lM, 7.5 lM, 15 lM and
20 lM of wild type WIF domain; (B) preincubated with 0 lM, 5 lM, 10 lM, 15 lM and 20 lM of WIF-I155R. Panel (C) shows the concentration dependence of the inhibitory
effect of WIF domains on the binding of Wnt5a-CTD as monitored by changes in observed association rate, kobs. Symbols: wild type WIF domain -j-j-; WIF-I155R -.-.-.
Lower row: sensorgrams of the interactions of immobilizedWIF domain with Wnt7a-CTD (500 nM) (D) preincubated with 0 lM, 2.5 lM, 5 lM, 10 lM and 20 lM of wild type
WIF domain; (E) preincubated with 0 lM, 5 lM, 7.5 lM, 10 lM and 20 lM of WIF-I155R. Panel (F) shows the concentration dependence of the inhibitory effect of WIF
domains on the binding of Wnt7a-CTD as monitored by changes in observed association rate, kobs. Symbols: wild type WIF domain -j-j-; WIF-I155R -.-.-. In these
experiments Wnt5a-CTD or Wnt7a-CTD were preincubated with various concentrations of wild type or Ile155Arg mutant WIF domains for 30 min at room temperature and
were injected over CM5 sensorchips containing immobilized wild type WIF domain (at 0 s on the abscissa). The binding phase lasted 240 s, followed by a washing phase.
Association and dissociation rate constants were calculated by analysis of the sensorgrams of the binding and washing phases, respectively. In each case SPR response
decreased parallel with the increase of WIF concentration.
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affinity for Wnt7a-CTD was more dramatic (Kd = 8.4  109 M?
Kd = 1.64  107 M).Our observation that the Ile155Arg mutation of WIF results in
elimination of detectable binding to Wnt5a-CTD, whereas
Wnt7a-CTD retains some affinity for the mutant (Table 4) suggests
Table 4
Kinetic parameters of the interaction of Wnt5a, Wnt7a, Wnt5a-CTD and Wnt7a-CTD with immobilized Ile155Arg WIF domain. The rate constants of the association and
dissociation reactions and the equilibrium dissociation constants of the interactions were determined from surface plasmon resonance measurements with the BIAevaluation
software 4.1.
Interacting proteins Kd (M) ka (1/Ms) kd (1/s)
WIF Ile155Arg – Wnt5a 1.55 ± 0.15  109 3.85 ± 0.44  105 5.98 ± 0.41  104
WIF Ile155Arg – Wnt7a 8.73 ± 0.34  1010 5.55 ± 8.82  105 4.84 ± 0.14  104
WIF Ile155Arg – Wnt5a-CTD nd* nd* nd*
WIF Ile155Arg – Wnt7a-CTD 1.64 ± 0.12  107 4.41 ± 0.19  103 7.23 ± 0.68  104
* nd – no detectable binding.
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significantly to the interaction.
In harmony with the notion that both the alkyl-binding site and
the Wnt-CTD binding site of the WIF domain are essential for the
high affinity of Wnts for WIF, WIF variants with double mutations
(e.g. Ile155Arg-Ile49Arg, in which residues at both the alkyl-
binding site and Wnt-CTD-binding site are substituted) have more
drastically reduced affinity for Wnt5a (Fig. 5, Table 3).A
C
Fig. 5. Effect of wild type and mutant WIF domains on the binding of Wnt5a to immobiliz
the interactions of immobilized WIF domain with Wnt5a (20 nM) (A) preincubated with
with 0 lM, 4 lM, 8 lM, 24 lM of WIF-I172R-F51R; (C) preincubated with 0 lM, 4 l
concentrations of wild type or mutant WIF domains for 30 min at room temperature and
(at 0 s on the abscissa). The binding phase lasted 240 s, followed by a washing phas
sensorgrams of the binding and washing phases, respectively. In each case SPR respon
concentration dependence of the inhibitory effect of WIF domains as monitored by chan
I155R-I49R -.-.-; WIF-I172R-F51R -s-s-.3.4. Modeling the interaction of the WIF domain with Wnts
Protein–protein docking with the ClusPro 2.0 server provided
some insight into the possible structures of the Wnt5a-WIF and
Wnt7a-WIF complexes that are consistent with the results of our
mutagenesis and protein–protein interactions studies. In these
docking experiments Wnt5a and Wnt7a were used as receptors
and the crystal structure of the WIF domain (2YGN.pdb) was usedB
D
ed wild type WIF domain, monitored by surface plasmon resonance. Sensorgrams of
0 lM, 0.25 lM, 0.5 lM, 2 lM and 4 lM of wild type WIF domain; (B) preincubated
M, 8 lM and 24 lM of WIF-I155R-I49R. Wnt5a was preincubated with various
were injected over CM5 sensorchips containing immobilized wild type WIF domain
e. Association and dissociation rate constants were calculated by analysis of the
se decreased parallel with the increase of WIF concentration. Panel (D) shows the
ges in observed association rate, kobs. Symbols: wild type WIF domain -j-j-; WIF-
Ile155
Phe66
Phe51
Ile49
Fig. 6. Wnt5a may grasp the WIF domain of WIF-1 at two distinct sites. Docking of
the WIF domain of WIF-1 to Wnt5a was performed with the ClusPro 2.0 server
(http://cluspro.bu.edu/login.php) using the WIF domain as ligand and Wnt5a as
receptor. The YASARA software (version 14.12.2) was used to visualize the Wnt5a-
WIF complexes. Residues Ile49, Phe51 and Phe66 of the alkyl-binding site of the
WIF domain involved in the binding of the N-terminal ‘thumbs’ of Wnts are shown
in green, residue Ile155 implicated in binding of the C-terminal ‘fingers’ of Wnts is
shown in yellow. For the sake of clarity the ribbon model of Wnt5a is shown.
3050 K. Kerekes et al. / FEBS Letters 589 (2015) 3044–3051as the ligand. The docking algorithms of ClusPro evaluate billions
of putative complexes, retaining those with favorable surface
complementarities [38,39]. Fig. 6 shows the structure of one of
the predicted Wnt5a-WIF complexes that might illustrate howIle74
Leu76
Tyr91
A
Fig. 7. The surfaces of the WIF domain of Ryk receptor tyrosine kinase likely to be involv
(the structural equivalents of Ile49, Phe51, Phe66 of WIF-1, whose substitution with argin
containing residue Thr173 (the structural equivalent of Ile155 of WIF-1, whose substitu
highlighted in yellow. Residue numbering refers to the numbering of human Ryk recept
tyrosine kinase was modeled on PDB 2YGN (see Supplementary file), the images were ge
around the y-axis.the C-terminal ‘finger’ of Wnt5a interacts with the Wnt-CTD bind-
ing site of the WIF domain, while the N-terminal ‘thumb’ of Wnt5a
binds to the alkyl-binding site of the WIF domain.
In view of the homology of the extracellular ligand-binding
domain of Ryk receptor tyrosine kinases with the WIF domain of
Wnt Inhibitory Factor 1 [15] and the fact that Ryk tyrosine kinases
serve as receptors for Wnts [17–22] our results may also have rel-
evance for structure–function aspects of these receptor tyrosine
kinases. Although the 3D structure of theWIF domain of Ryk recep-
tor tyrosine kinase is not yet known, its homology with the WIF
domain of WIF-1 permitted us to build a homology model for the
domain (Fig. 7). Comparison of the predicted structure of Ryk’s
WIF domain (Fig. 7) with the structure of the WIF domain of Wnt
Inhibitory Factor 1 (Fig. 3) identified Ryk residues Ile74, Leu76,
Tyr91, Thr173 (the structural equivalents of Ile49, Phe51, Phe66
and Ile155 of WIF-1) as the most likely Wnt-binding binding sites
in Ryk receptor tyrosine kinases.
4. Discussion
In the present work we have shown that – in addition to the
alkyl-binding site – a second site at the opposite surface of the
WIF domain is critical for its interaction with Wnts. The fact that
the Ile155Arg substitution at this second site drastically reduces
binding to Wnt5a-CTD and Wnt7a-CTD clearly establishes that
the C-terminal cytokine-like ‘finger’ domain of Wnts binds to this
second site of the WIF domain. Conversely, the fact that mutations
affecting the alkyl-binding site of the WIF domain weaken the
WIF–Wnt interaction [36], but have no influence on the interaction
of WIF with Wnt5a-CTD or Wnt7a-CTD is consistent with the
notion that the alkyl-binding site may be involved in the binding
of the lipid-modified, N-terminal ‘thumb’ of Wnts.
Understanding the structural basis of the Wnt–WIF interaction
is of major importance as it might permit the design of WIF vari-
ants with improved therapeutic properties.
The therapeutic importance of Wnt Inhibitory Factor 1 may be
illustrated by the fact that epigenetic silencing of WIF-1 is associ-
ated with aberrant activation of the Wnt pathways in a variety ofThr173
 B
ed in its interaction with Wnts. (A) Surface containing residues Ile74, Leu76, Tyr91
ine resulted in weaker binding for Wnt5a [36]) are highlighted in green. (B) Surface
tion with arginine resulted in weaker binding for Wnt5a-CTD and Wnt7a-CTD) is
or tyrosine kinase protein in UniProtKB – P34925. The WIF domain of Ryk receptor
nerated by YASARA version 7.10.31. (B) was generated by rotating figure (A) by 225
K. Kerekes et al. / FEBS Letters 589 (2015) 3044–3051 3051cancers, whereas restoration of its expression inhibits tumor pro-
gression [32–34]. The significance of WIF-1 as a tumor suppressor
is also supported by the recent observation that a Cys294Phe
mutation of the WIF1 gene predisposes members of a large family
to multiple early onset cancers including prostate, breast, colon,
and several other uncommon cancers [40]. Since the Cys294Phe
mutation disrupts a conserved disulfide bond of the fourth EGF
domain of the WIF-1 protein it seems plausible to assume that
the misfolded protein is unable to fulfill its function as a negative
regulator of various Wnts, leading to aberrant activation of the var-
ious Wnt-Fzd-LRP5/LRP6 signaling pathways.
In view of the growing interest in developing therapies that
exploit inhibitors of the Wnt pathway [41,42] it is important to
point out that inhibition of Wnt signaling by transfection with vec-
tors coding for WIF-1 or treatment with recombinant WIF domain
reduced tumor growth in several models [32–33,43].
We believe that understanding the structure of Wnt–WIF com-
plexes promotes the rational design of WIF variants, permitting
more specific targeting of Wnt family members and more specific
targeting of distinct forms of cancer.
Acknowledgments
This work was supported by Grant K75836 of OTKA (National
Scientific Research Fund of Hungary, OTKA) and Grant 001-
07/2009 of ETT (Medical Research Council, Hungary).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2015.08.
031.
References
[1] van Amerongen, R. and Nusse, R. (2009) Towards an integrated view of Wnt
signaling in development. Development 136, 3205–3214.
[2] Nusse, R., Fuerer, C., Ching, W., Harnish, K., Logan, C., Zeng, A., ten Berge, D. and
Kalani, Y. (2008) Wnt signaling and stem cell control. Cold Spring Harb. Symp.
Quant. Biol. 73, 59–66.
[3] Clark, C.E., Nourse, C.C. and Cooper, H.M. (2012) The tangled web of non-
canonical Wnt signalling in neural migration. Neurosignals 20, 202–220.
[4] van Amerongen, R., Mikels, A. and Nusse, R. (2008) Alternative wnt signaling is
initiated by distinct receptors. Sci. Signal. 1 (35), re9.
[5] Kestler, H.A. and Kuhl, M. (2008) From individual Wnt pathways towards a
Wnt signalling network. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 1333–1347.
[6] Boutros, M., Paricio, N., Strutt, D.I. and Mlodzik, M. (1998) Dishevelled
activates JNK and discriminates between JNK pathways in planar polarity and
wingless signaling. Cell 94, 109–118.
[7] Wu, C.H. and Nusse, R. (2002) Ligand receptor interactions in the Wnt
signaling pathway in Drosophila. J. Biol. Chem. 277, 41762–41769.
[8] Hsieh, J.C. (2004) Specificity of WNT-receptor interactions. Front. Biosci. 9,
1333–1338.
[9] Saldanha, J., Singh, J. and Mahadevan, D. (1998) Identification of a Frizzled-like
cysteine rich domain in the extracellular region of developmental receptor
tyrosine kinases. Protein Sci. 7, 1632–1635.
[10] Masiakowski, P. and Yancopoulos, G.D. (1998) The Wnt receptor CRD domain
is also found in MuSK and related orphan receptor tyrosine kinases. Curr. Biol.
8, R407.
[11] Xu, Y.K. and Nusse, R. (1998) The Frizzled CRD domain is conserved in diverse
proteins including several receptor tyrosine kinases. Curr. Biol. 8, R405–R406.
[12] Hikasa, H., Shibata, M., Hiratani, I. and Taira, M. (2002) The Xenopus receptor
tyrosine kinase Xror2 modulates morphogenetic movements of the axial
mesoderm and neuroectoderm via Wnt signaling. Development 129, 5227–
5239.
[13] Oishi, I., Suzuki, H., Onishi, N., Takada, R., Kani, S., Ohkawara, B., Koshida, I.,
Suzuki, K., Yamada, G., Schwabe, G.C., Mundlos, S., Shibuya, H., Takada, S. and
Minami, Y. (2003) The receptor tyrosine kinase Ror2 is involved in non-
canonical Wnt5a/JNK signalling pathway. Genes Cells 8, 645–654.[14] Li, C., Chen, H., Hu, L., Xing, Y., Sasaki, T., Villosis, M.F., Li, J., Nishita, M.,
Minami, Y. and Minoo, P. (2008) Ror2 modulates the canonical Wnt signaling
in lung epithelial cells through cooperation with Fzd2. BMC Mol. Biol. 9, 11.
[15] Hsieh, J.C., Kodjabachian, L., Rebbert, M.L., Rattner, A., Smallwood, P.M., Samos,
C.H., Nusse, R., Dawid, I.B. and Nathans, J. (1999) A new secreted protein that
binds to Wnt proteins and inhibits their activities. Nature 398, 431–436.
[16] Patthy, L. (2000) The WIF module. Trends Biochem. Sci. 25, 12–13.
[17] Yoshikawa, S., McKinnon, R.D., Kokel, M. and Thomas, J.B. (2003) Wnt-
mediated axon guidance via the Drosophila derailed receptor. Nature 422,
583–588.
[18] Lu, W., Yamamoto, V., Ortega, B. and Baltimore, D. (2004) Mammalian Ryk is a
Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119, 97–
108.
[19] Inoue, T., Oz, H.S., Wiland, D., Gharib, S., Deshpande, R., Hill, R.J., Katz, W.S. and
Sternberg, P.W. (2004) C. elegans LIN-18 is a Ryk ortholog and functions in
parallel to LIN-17/Frizzled in Wnt signaling. Cell 118, 795–806.
[20] Keeble, T.R. and Cooper, H.M. (2006) Ryk: a novel Wnt receptor regulating
axon pathfinding. Int. J. Biochem. Cell Biol. 38, 2011–2017.
[21] Cadigan, K.M. and Liu, Y.I. (2006) Wnt signaling: complexity at the surface. J.
Cell Sci. 119 (Pt 3), 395–402.
[22] Kim, G.H., Her, J.H. and Han, J.K. (2008) Ryk cooperates with Frizzled 7 to
promote Wnt11-mediated endocytosis and is essential for Xenopus laevis
convergent extension movements. J. Cell Biol. 182, 1073–1082.
[23] Katoh, M. and Katoh, M. (2007) WNT signaling pathway and stem cell
signaling network. Clin. Cancer Res. 13, 4042–4045.
[24] Willert, K., Brown, J.D., Danenberg, E., Duncan, A.W., Weissman, I.L., Reya, T.,
Yates 3rd, J.R. and Nusse, R. (2003) Wnt proteins are lipid-modified and can
act as stem cell growth factors. Nature 423, 448–452.
[25] Doubravska, L., Krausova, M., Gradl, D., Vojtechova, M., Tumova, L., Lukas, J.,
Valenta, T., Pospichalova, V., Fafilek, B., Plachy, J., Sebesta, O. and Korinek, V.
(2011) Fatty acid modification of Wnt1 and Wnt3a at serine is prerequisite for
lipidation at cysteine and is essential for Wnt signalling. Cell. Signal. 23, 837–
848.
[26] Nusse, R. (2015) Cell signalling: disarming Wnt. Nature 519, 163–164.
[27] Kakugawa, S., Langton, P.F., Zebisch, M., Howell, S.A., Chang, T.-H., Liu, Y., Feizi,
T., Bineva, G., O’Reilly, N., Snijders, A.P., Yvonne Jones, E. and Vincent, J.-P.
(2015) Notum deacylates Wnt proteins to suppress signalling activity. Nature
519, 187–192.
[28] Janda, C.Y., Waghray, D., Levin, A.M., Thomas, C. and Garcia, K.C. (2012)
Structural basis of Wnt recognition by Frizzled. Science 337, 59–64.
[29] Bazan, J.F., Janda, C.Y. and Garcia, K.C. (2012) Structural architecture and
functional evolution of Wnts. Dev. Cell 23, 227–232.
[30] MacDonald, B.T., Hien, A., Zhang, X., Iranloye, O., Virshup, D.M., Waterman, M.
L. and He, X. (2014) Disulfide bond requirements for active Wnt ligands. J. Biol.
Chem. 289, 18122–18136.
[31] Chu, M.L., Ahn, V.E., Choi, H.J., Daniels, D.L., Nusse, R. and Weis, W. (2013)
Structural studies of Wnts and identification of an LRP6 binding site. Structure
21, 1235–1242.
[32] Kawano, Y. and Kypta, R. (2003) Secreted antagonists of the Wnt signalling
pathway. J. Cell Sci. 116, 2627–2634.
[33] Filipovich, A., Gehrke, I., Poll-Wolbeck, S.J. and Kreuzer, K.A. (2011)
Physiological inhibitors of Wnt signaling. Eur. J. Haematol. 86, 453–465.
[34] Malinauskas, T. and Jones, E.Y. (2014) Extracellular modulators of Wnt
signalling. Curr. Opin. Struct. Biol. 29, 77–84.
[35] Liepinsh, E., Banyai, L., Patthy, L. and Otting, G. (2006) NMR structure of the
WIF domain of the human Wnt-inhibitory factor-1. J. Mol. Biol. 357, 942–950.
[36] Banyai, L., Kerekes, K. and Patthy, L. (2012) Characterization of a Wnt-binding
site of the WIF-domain of Wnt inhibitory factor-1. FEBS Lett. 586, 3122–3126.
[37] Malinauskas, T., Aricescu, A.R., Lu, W., Siebold, C. and Jones, E.Y. (2011)
Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1.
Nat. Struct. Mol. Biol. 18, 886–893.
[38] Comeau, S.R., Gatchell, D.W., Vajda, S. and Camacho, C.J. (2004) ClusPro: a fully
automated algorithm for protein–protein docking. Nucleic Acids Res. 32,
W96–W99.
[39] Comeau, S.R., Gatchell, D.W., Vajda, S. and Camacho, C.J. (2004) ClusPro: an
automated docking and discrimination method for the prediction of protein
complexes. Bioinformatics 20, 45–50.
[40] Wei, C., Peng, B., Han, Y., Chen, W.V., Rother, J., Tomlinson, G.E., Boland, C.R.,
Chaussabel, M., Frazier, M.L. and Amos, C.I. (2015) Mutations of HNRNPA0 and
WIF1 predispose members of a large family to multiple cancers. Fam. Cancer
14, 297–306.
[41] Baarsma, H.A., Konigshoff, M. and Gosens, R. (2013) The WNT signaling
pathway from ligand secretion to gene transcription: molecular mechanisms
and pharmacological targets. Pharmacol. Ther. 138, 66–83.
[42] Anastas, J.N. and Moon, R.T. (2013) WNT signalling pathways as therapeutic
targets in cancer. Nat. Rev. Cancer 13, 11–26.
[43] Lin, Y.C., You, L., Xu, Z., He, B., Yang, C.T., Chen, J.K., Mikami, I., Clement, G., Shi,
Y., Kuchenbecker, K., Okamoto, J., Kashani-Sabet, M. and Jablons, D.M. (2007)
Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth. Hum.
Gene Ther. 18, 379–386.
